Austria
Liquid biopsy, circulating tumor DNA (ctDNA), colorectal cancer, FOLFOX (FOLinic acid (leucovorin), Fluorouracil (5-FU), Oxaliplatin), predictive biomarker, response evaluation, personalized outcome prediction